Εξώφυλλο

A case of nearly complete response in hepatocellular carcinoma with disseminated lung metastasis by combination therapy of nivolumab and ipilimumab after treatment failure of atezolizumab plus bevacizumab

Recently, the efficacy of immuno-oncologic agents for advanced hepatocellular carcinoma (HCC) has been proven in several trials. In particular, atezolizumab with bevacizumab (AteBeva), as a first-line therapy for advanced HCC, has shown tremendous advances in the IMBrave150 study. However, second or...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Hyung Jun Kim (Συγγραφέας), Sang Youn Hwang (Συγγραφέας), Jung Woo Im (Συγγραφέας), Ki Jeong Jeon (Συγγραφέας), Wan Jeon (Συγγραφέας)
Μορφή:	Βιβλίο
Έκδοση:	Korean Liver Cancer Association, 2023-03-01T00:00:00Z.
Θέματα:	article
Διαθέσιμο Online:	Connect to this object online.
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια

Complete response in hepatocellular carcinoma with lymph node metastasis by combination therapy of atezolizumab and bevacizumab: a case report
από: Sang Youn Hwang, κ.ά.
Έκδοση: (2021)

A Case of Pseudoprogression in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
από: Yukinobu Watanabe MD, PhD, κ.ά.
Έκδοση: (2021)

Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis
από: Jeayeon Park, κ.ά.
Έκδοση: (2024)

Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab
από: Tae Hyun Kim, κ.ά.
Έκδοση: (2023)

Letter regarding "Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab"
από: Sun Hyun Bae, κ.ά.
Έκδοση: (2023)

Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients
από: Zhou S, κ.ά.
Έκδοση: (2019)

Exposure‐response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)
από: Bruno Sangro, κ.ά.
Έκδοση: (2023)

Favorable response of hepatocellular carcinoma with portal vein tumor thrombosis after radiotherapy combined with atezolizumab plus bevacizumab
από: Yong Tae Kim, κ.ά.
Έκδοση: (2023)

Comparative Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Advanced Cancer: A Systematic Review and Meta-Analysis
από: Yi Yang, κ.ά.
Έκδοση: (2020)

Atezolizumab plus bevacizumab and chemotherapy versus bevacizumab plus chemotherapy for metastatic cervical cancer: a cost-effectiveness analysis
από: Hongfu Cai, κ.ά.
Έκδοση: (2024)

A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment
από: Yuri Cho, κ.ά.
Έκδοση: (2023)

Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer
από: Xiaomin Wan, κ.ά.
Έκδοση: (2021)

Urticaria multiforme following nivolumab-ipilimumab therapy
από: Sonal Muzumdar, κ.ά.
Έκδοση: (2020)

Ipilimumab and nivolumab for recurrent neuroendocrine cervical carcinoma
από: Mary Towner, κ.ά.
Έκδοση: (2022)

CLINICAL AND ECONOMIC EVALUATION OF ATEZOLIZUMAB + VEMURAFENIB + COBIMETINIB COMBINATION AND NIVOLUMAB + IPILIMUMAB COMBINATION: ADMINISTRATION IN METASTATIC MELANOMA TREATMENT WITH BRAF-CONFIRMED MUTATION IN ADULT PATIENTS
από: I. S. Krysanov, κ.ά.
Έκδοση: (2022)

Pediatric model‐based dose optimization using a pooled exposure-response safety analysis for nivolumab and nivolumab plus ipilimumab combination in melanoma
από: Shengnan Du, κ.ά.
Έκδοση: (2024)

Atezolizumab Plus Bevacizumab-induced Recalcitrant Pyoderma Gangrenosum Treated with Baricitinib: A Case Report
από: Han Seul Kim, κ.ά.
Έκδοση: (2023)

Cost-effectiveness of nivolumab plus ipilimumab as first-line treatment for American patients with unresectable malignant pleural mesothelioma
από: Zhuo-miao Ye, κ.ά.
Έκδοση: (2022)

Cost-Effectiveness of Nivolumab Plus Ipilimumab as First-Line Therapy in Advanced Non-small-cell Lung Cancer
από: Xuezhi Hao, κ.ά.
Έκδοση: (2021)

Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma
από: Matthew D. Tucker, κ.ά.
Έκδοση: (2021)

Pustular psoriasis triggered by therapy with atezolizumab and bevacizumab
από: Mariani Magnus da Luz Andrade, κ.ά.
Έκδοση: (2024)

Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination
από: Takahiro Niimura, κ.ά.
Έκδοση: (2023)

Downstaging with atezolizumab-bevacizumab: a case series
από: Anand V. Kulkarni, κ.ά.
Έκδοση: (2024)

Cure can be achieved by conversion to microwave ablation following atezolizumab-bevacizumab therapy in unresectable hepatocellular carcinoma
από: Rene John D. Febro, κ.ά.
Έκδοση: (2024)

Hyperprogression in a Patient With Hepatocellular Cancer Treated With Atezolizumab and Bevacizumab: A Case Report and Review of Literature
από: Balraj Singh MD, κ.ά.
Έκδοση: (2021)

A case of ruptured Baker's cyst induced by nivolumab and ipilimumab
από: Marie Kubo, κ.ά.
Έκδοση: (2023)

Population Pharmacokinetics of Nivolumab in Combination With Ipilimumab in Patients With Advanced Malignancies
από: Jason Zhang, κ.ά.
Έκδοση: (2019)

Antitumor Activity and Treatment-Related Toxicity Associated With Nivolumab Plus Ipilimumab in Advanced Malignancies: A Systematic Review and Meta-Analysis
από: Hang Xu, κ.ά.
Έκδοση: (2019)

Nivolumab plus ipilimumab with chemotherapy in metastatic NSCLC: minireview and a case study of a patient negative for PD-L1
από: Alessandro Morabito
Έκδοση: (2024)

Population Pharmacokinetics of Ipilimumab in Combination With Nivolumab in Patients With Advanced Solid Tumors
από: Kinjal Sanghavi, κ.ά.
Έκδοση: (2020)

Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report
από: Ji Eun Han, κ.ά.
Έκδοση: (2021)

Photosensitive Dermatitis Induced by Nivolumab/Ipilimumab Combination Therapy in a Patient with Malignant Melanoma
από: Yuri Sakaguchi, κ.ά.
Έκδοση: (2020)

Ipilimumab and Nivolumab induced ventricular tachycardia in a patient with metastatic renal cell carcinoma
από: Pramod Savarapu, κ.ά.
Έκδοση: (2021)

Concurrent transarterial radioembolization and combination atezolizumab/bevacizumab treatment of infiltrative hepatocellular carcinoma with portal vein tumor thrombosis: a case report
από: Min Kyung Park, κ.ά.
Έκδοση: (2022)

Effectiveness and safety of atezolizumab, nivolumab and pembrolizumab in metastatic non-small cell lung cancer
από: Amparo Burgos-San José, κ.ά.
Έκδοση: (2021)

Sequential therapy with INCAGN01949 followed by ipilimumab and nivolumab in two patients with advanced ovarian carcinoma
από: Andrey Moiseyenko, κ.ά.
Έκδοση: (2020)

Checkpoint inhibitor immunotherapy induced inflammatory arthritis secondary to Nivolumab and Ipilimumab: a pediatric first
από: John A. Storwick, κ.ά.
Έκδοση: (2024)

Nivolumab and Ipilimumab Acting as Tormentors of Advanced Tumors by Unleashing Immune Cells and Associated Collateral Damage
από: Bushra Khan, κ.ά.
Έκδοση: (2024)

Hyponatremia and Fever in a Patient on Ipilimumab and Nivolumab (Immune Checkpoint Inhibitors): A Case Report
από: Sumit S. Patel MD, κ.ά.
Έκδοση: (2021)

Lichen striatus as an immune-related adverse event following ipilimumab/nivolumab and COVID-19 infection in an adult
από: Courtney M. Kenyon, BS, κ.ά.
Έκδοση: (2024)